Načítá se...
Hepatocellular carcinoma after direct-acting antiviral therapy for chronic HCV infection: Is it a real risk?
The newer oral treatments for chronic hepatitis C virus infection are one of the greatest revolutions in modern medicine. These drugs promise to eradicate the infection, showing high cure rates even in difficult to treat populations with very few side effects. Nevertheless, some cases of recurrence...
Uloženo v:
| Vydáno v: | IDCases |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6125765/ https://ncbi.nlm.nih.gov/pubmed/30191133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.idcr.2018.e00450 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|